We are a health technology company that offers DNA screening for men, women, and their children. Our philosophy is simple: focus on diseases where advanced knowledge makes a difference in health outcomes.
Our team consists of top-tier engineers, scientists, and healthcare professionals who work together to provide people with meaningful health data.
We integrate sophisticated technology with custom automation in our CLIA-approved, CAP-accredited and NYS CLEP-certified medical laboratory.
Counsyl partners with healthcare providers to enable broader access to genetic screening. The Counsyl platform extends beyond family preparation to include pregnancy screening and inherited cancer screening.
Led by co-founders Ramji Srinivasan, CEO; Eric Evans, Chief Scientist; and Rishi Kacker, VP of Engineering, Counsyl has raised a total of $102M and is privately funded by Founders Fund, Pilot Growth Equity, Goldman Sachs Asset Management, Felicis Ventures, and other prominent investors.